MENU
TELO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Telomir Pharmaceuticals (TELO) Ownership - Who owns Telomir Pharmaceuticals?
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science... Show more
Profile
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
86.01M
P/E Ratio
N/A
Total Cash
1.27M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TELO
Capitalization
86M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.27M
Total Cash/Share
0.04
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
643K
P/B Ratio
133.33
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
1.94
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-12.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-542.25
Shares Held By Institutions
27.2M
Shares Outstanding - Current
29.8M
Total Liabilities
681K
Total Volume MTD
N/A
Value
-1
Gain YTD
-29.854
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
855 N Wolfe Street
Phone
+1 737 289-0835
Employees
9
Web
https://www.telomirpharma.com